Send us Feedback

Advanced Medical Optics (EYE)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
OPERATING METRICS
REVENUE SOURCES
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

EYE » Topics » SIGNATURES

This excerpt taken from the EYE 8-K filed Feb 27, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Abbott Medical Optics Inc.
By:   /s/ Aimee S. Weisner
  Aimee S. Weisner
  Executive Vice President, Administration and Secretary

Date: February 27, 2009

This excerpt taken from the EYE 8-K filed Feb 25, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Advanced Medical Optics, Inc.
By:   /s/ Aimee S. Weisner
  Aimee S. Weisner
  Executive Vice President, Administration and Secretary

Date: February 25, 2009

These excerpts taken from the EYE 10-K filed Feb 24, 2009.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: February 19, 2009   ADVANCED MEDICAL OPTICS, INC.
  By  

/s/ JAMES. V. MAZZO

    James V. Mazzo
    Chairman of the Board and Chief Executive Officer

We, the undersigned directors and officers of Advanced Medical Optics, Inc., hereby severally constitute James V. Mazzo and Aimee S. Weisner, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, in our names in the capacities indicated below, any and all amendments to this Annual Report on Form 10-K filed with the Securities and Exchange Commission.

 

154

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the date indicated.

 

Date: February 19, 2009   By  

/s/ JAMES. V. MAZZO

    James V. Mazzo
   

Chairman of the Board and Chief Executive Officer

(Principal Executive Officer)

Date: February 19, 2009   By  

/s/ MICHAEL J. LAMBERT

    Michael J. Lambert
   

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: February 19, 2009   By  

/s/ ROBERT F. GALLAGHER

    Robert F. Gallagher
    Senior Vice President. Chief Accounting Officer and Controller (Principal Accounting Officer)
Date: February 19, 2009   By  

/s/ CHRISTOPHER G. CHAVEZ

    Christopher G. Chavez, Director
Date: February 19, 2009   By  

/s/ ELIZABETH H. DÁVILA

    Elizabeth H. Dávila, Director
Date: February 23, 2009   By  

/s/ DANIEL J. HEINRICH

    Daniel J. Heinrich, Director
Date: February 19, 2009   By  

/s/ WILLIAM J. LINK, PH.D.

    William J. Link, Ph.D., Director
Date: February 19, 2009   By  

/s/ G. MASON MORFIT

    G. Mason Morfit, Director
Date: February 19, 2009   By  

/s/ MICHAEL A. MUSSALLEM

    Michael A. Mussallem, Director
Date: February 19, 2009   By  

/s/ DEBORAH J. NEFF

    Deborah J. Neff, Director
Date: February 19, 2009   By  

/s/ ROBERT J. PALMISANO

    Robert J. Palmisano, Director
Date: February 19, 2009   By  

/s/ JAMES O. ROLLANS

    James O. Rollans, Presiding Director

 

155

Table of Contents

SIGNATURES

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

 




































Date: February 19, 2009 ADVANCED MEDICAL OPTICS, INC.
 By 

/s/ JAMES. V. MAZZO

  James V. Mazzo
  Chairman of the Board and Chief Executive Officer

We, the undersigned directors and officers of Advanced Medical Optics, Inc., hereby severally
constitute James V. Mazzo and Aimee S. Weisner, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, in our names in the capacities indicated below, any and all amendments to this Annual
Report on Form 10-K filed with the Securities and Exchange Commission.

 


154






Table of Contents


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by
the following persons on behalf of the Registrant and in the capacities and on the date indicated.

 
























































































































































































































Date: February 19, 2009 By 

/s/ JAMES. V. MAZZO

  James V. Mazzo
  

Chairman of the Board and Chief Executive Officer

SIZE="2">(Principal Executive Officer)

Date: February 19, 2009 By 

/s/ MICHAEL J. LAMBERT

  Michael J. Lambert
  

Executive Vice President and Chief Financial Officer

SIZE="2">(Principal Financial Officer)

Date: February 19, 2009 By 

/s/ ROBERT F. GALLAGHER

  Robert F. Gallagher
  Senior Vice President. Chief Accounting Officer and Controller (Principal Accounting Officer)
Date: February 19, 2009 By 

/s/ CHRISTOPHER G. CHAVEZ

  Christopher G. Chavez, Director
Date: February 19, 2009 By 

/s/ ELIZABETH H. DÁVILA

  Elizabeth H. Dávila, Director
Date: February 23, 2009 By 

/s/ DANIEL J. HEINRICH

  Daniel J. Heinrich, Director
Date: February 19, 2009 By 

/s/ WILLIAM J. LINK, PH.D.

  William J. Link, Ph.D., Director
Date: February 19, 2009 By 

/s/ G. MASON MORFIT

  G. Mason Morfit, Director
Date: February 19, 2009 By 

/s/ MICHAEL A. MUSSALLEM

  Michael A. Mussallem, Director
Date: February 19, 2009 By 

/s/ DEBORAH J. NEFF

  Deborah J. Neff, Director
Date: February 19, 2009 By 

/s/ ROBERT J. PALMISANO

  Robert J. Palmisano, Director
Date: February 19, 2009 By 

/s/ JAMES O. ROLLANS

  James O. Rollans, Presiding Director

 


155






Table of Contents


SIGNATURES

STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.

 




































Date: February 19, 2009 ADVANCED MEDICAL OPTICS, INC.
 By 

/s/ JAMES. V. MAZZO

  James V. Mazzo
  Chairman of the Board and Chief Executive Officer

We, the undersigned directors and officers of Advanced Medical Optics, Inc., hereby severally
constitute James V. Mazzo and Aimee S. Weisner, and each of them singly, our true and lawful attorneys with full power to them and each of them to sign for us, in our names in the capacities indicated below, any and all amendments to this Annual
Report on Form 10-K filed with the Securities and Exchange Commission.

 


154






Table of Contents


Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by
the following persons on behalf of the Registrant and in the capacities and on the date indicated.

 
























































































































































































































Date: February 19, 2009 By 

/s/ JAMES. V. MAZZO

  James V. Mazzo
  

Chairman of the Board and Chief Executive Officer

SIZE="2">(Principal Executive Officer)

Date: February 19, 2009 By 

/s/ MICHAEL J. LAMBERT

  Michael J. Lambert
  

Executive Vice President and Chief Financial Officer

SIZE="2">(Principal Financial Officer)

Date: February 19, 2009 By 

/s/ ROBERT F. GALLAGHER

  Robert F. Gallagher
  Senior Vice President. Chief Accounting Officer and Controller (Principal Accounting Officer)
Date: February 19, 2009 By 

/s/ CHRISTOPHER G. CHAVEZ

  Christopher G. Chavez, Director
Date: February 19, 2009 By 

/s/ ELIZABETH H. DÁVILA

  Elizabeth H. Dávila, Director
Date: February 23, 2009 By 

/s/ DANIEL J. HEINRICH

  Daniel J. Heinrich, Director
Date: February 19, 2009 By 

/s/ WILLIAM J. LINK, PH.D.

  William J. Link, Ph.D., Director
Date: February 19, 2009 By 

/s/ G. MASON MORFIT

  G. Mason Morfit, Director
Date: February 19, 2009 By 

/s/ MICHAEL A. MUSSALLEM

  Michael A. Mussallem, Director
Date: February 19, 2009 By 

/s/ DEBORAH J. NEFF

  Deborah J. Neff, Director
Date: February 19, 2009 By 

/s/ ROBERT J. PALMISANO

  Robert J. Palmisano, Director
Date: February 19, 2009 By 

/s/ JAMES O. ROLLANS

  James O. Rollans, Presiding Director

 


155






Table of Contents


This excerpt taken from the EYE 8-K filed Feb 24, 2009.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Advanced Medical Optics, Inc.

 

 

 

 

 

By:

  /s/ Aimee S. Weisner

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

Date: February 24, 2009

 

3

This excerpt taken from the EYE 8-K filed Feb 20, 2009.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Advanced Medical Optics, Inc.

 

 

 

 

 

 

 

By:

/s/ Aimee S. Weisner

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

Date: February 20, 2009

 

3


 

This excerpt taken from the EYE 8-K filed Feb 17, 2009.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Advanced Medical Optics, Inc.

 

 

 

 

 

 

 

By:

/s/ Aimee S. Weisner

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

 

 

 

 

Date: February 17, 2009

 

 

 

3


 

This excerpt taken from the EYE 8-K filed Feb 4, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

ADVANCED MEDICAL OPTICS, INC.

(Registrant)

Date: February 4, 2009     By:   /s/ AIMEE S. WEISNER
     

Aimee S. Weisner,

Executive Vice President, Administration, and Secretary

This excerpt taken from the EYE 8-K filed Jan 27, 2009.

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ADVANCED MEDICAL OPTICS, INC.

 

 

 

 

 

 

 

By:

/s/ AIMEE S. WEISNER

 

 

Aimee S. Weisner

 

 

Executive Vice President, Administration and Secretary

 

 

Date: January 27, 2009

 

3


 

This excerpt taken from the EYE 8-K filed Jan 7, 2009.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ADVANCED MEDICAL OPTICS, INC.
                  (Registrant)
Date: January 7, 2009     By:   /s/ AIMEE S. WEISNER
        Aimee S. Weisner,
        Executive Vice President, Administration, and Secretary
This excerpt taken from the EYE 8-K filed Dec 23, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

ADVANCED MEDICAL OPTICS, INC.

(Registrant)

Date: December 23, 2008

     By:   /s/ AIMEE S. WEISNER
     

Aimee S. Weisner,

Executive Vice President, Administration, and Secretary

This excerpt taken from the EYE 8-K filed Dec 16, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ADVANCED MEDICAL OPTICS, INC.
                            (Registrant)
Date: December 16, 2008     By:   /s/ AIMEE S. WEISNER
      Aimee S. Weisner,
     

Executive Vice President,

Administration, and Secretary

 

 

 

 

This excerpt taken from the EYE 8-K filed Nov 19, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

ADVANCED MEDICAL OPTICS, INC.

            (Registrant)

Date: November 19, 2008     By:   /s/ AIMEE S. WEISNER
       

Aimee S. Weisner,

Executive Vice President,

Administration, and Secretary

This excerpt taken from the EYE 8-K filed Nov 7, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ADVANCED MEDICAL OPTICS, INC.
   

(Registrant)

Date: November 7, 2008     By:   /s/ AIMEE S. WEISNER
        Aimee S. Weisner,
        Executive Vice President, Administration, and Secretary

This excerpt taken from the EYE 8-K filed Oct 31, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

ADVANCED MEDICAL OPTICS, INC.

                            (Registrant)

Date: October 31, 2008     By:   /s/ MICHAEL J. LAMBERT
       

Michael J. Lambert,

Executive Vice President and

Chief Financial Officer

 

This excerpt taken from the EYE 8-K filed Oct 20, 2008.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ADVANCED MEDICAL OPTICS, INC.
 

(Registrant)

Date: October 20, 2008

   By:  

/s/ MICHAEL J. LAMBERT

    Michael J. Lambert,
    Executive Vice President and Chief Financial Officer

 

EXCERPTS ON THIS PAGE:

8-K
Feb 27, 2009
8-K
Feb 25, 2009
10-K (3 sections)
Feb 24, 2009
8-K
Feb 24, 2009
8-K
Feb 20, 2009
8-K
Feb 17, 2009
8-K
Feb 4, 2009
8-K
Jan 27, 2009
8-K
Jan 7, 2009
8-K
Dec 23, 2008
8-K
Dec 16, 2008
8-K
Nov 19, 2008
8-K
Nov 7, 2008
8-K
Oct 31, 2008
8-K
Oct 20, 2008

RELATED TOPICS for EYE:

"SIGNATURES" elsewhere:

Boston Scientific (BSX)
ABIOMED (ABMD)
Antares Pharma (AIS)
MGC DIAGNOSTICS Corp (ANGN)
AngioDynamics (ANGO)
Alphatec Holdings (ATEC)
AtriCure (ATRC)
BARD C R INC (BCR)
BECTON DICKINSON & CO (BDX)
BioLase Technology (BLTI)
CAS Medical Systems (CASM)
Cantel Medical (CMN)
Cooper Companies (COO)
Conceptus (CPTS)
Haemonetics (HAE)
Home Diagnostics (HDIX)
Integra LifeSciences Holdings (IART)
ICU Medical (ICUI)
Kensey Nash (KNSY)
LeMaitre Vascular (LMAT)
Mesa Laboratories (MLAB)
Merit Medical Systems (MMSI)
Mindray Medical International (MR)
Memry (MRY)
NUCRYST Pharmaceuticals (NCST)
NuVasive (NUVA)
Osteotech (OSTE)
OraSure Technologies (OSUR)
Insulet (PODD)
Protherics (PTIL)
Rochester Medical (ROCM)
Retractable Technologies (RVP)
SenoRx (SENO)
SonoSite (SONO)
STAAR Surgical Company (STAA)
Stryker (SYK)
Teleflex (TFX)
Uroplasty (UPI)
Vascular Solutions (VASC)
Orthovita (VITA)
West Pharmaceutical Services (WST)
DENTSPLY International (XRAY)
Young Innovations (YDNT)
Zila (ZILA)
Baxter International (BAX)
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki